LV-DC vaccine / SZGIMI 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LV-DC vaccine / SZGIMI
NCT04276896: Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Recruiting
1/2
100
RoW
Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs
Shenzhen Geno-Immune Medical Institute, Shenzhen Third People's Hospital, Shenzhen Second People's Hospital
Pathogen Infection Covid-19 Infection
07/23
12/24

Download Options